Consonance Capital Management is Fond of Healthcare Stocks

Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD. The firm usually invests in the lower middle market, in value stocks of small and mid-cap companies, focusing on the healthcare sector (payors, pharmaceutical, specialty distributors, and device manufacturers). CEO Mitchell Blutt uses his medical training and knowledge to identify attractive investment opportunities, companies with potential, within this segment. Before founding Consonance Capital, Mr. Blutt worked as Executive Partner at J.P. Morgan Partners.

A few days ago, the fund filed a Form 13F at the SEC, disclosing its long equity positions as of March 31 2014. It declared holding 37 different positions, all of them in the healthcare sector. Newcommers in the portfolio were represented by 10 of these holdings, and another 14 saw the fund increase its stakes over the quarter. Let’s take a closer look at the top holdings in this portfolio, valued at more than $672 million, and some of the moves that took place over Q1.

United Therapeutics Corporation (NASDAQ:UTHR)

Mr. Blutt’s top position remained the same: United Therapeutics Corporation (NASDAQ:UTHR). In fact, this $4.8 billion market cap biotechnology company saw the fund’s stakes increase by 15% over Q1. Consonance now owns 669,690 shares of the company, worth more than $67 million, which accounts for more than 9% of the total value of its equity portfolio. This makes it the second largest hedge fund shareholder, only trailing William Leland Edwards’ Palo Alto Investors, which owns 1.1 million shares.

The second place was occupied by a new stock in Consonance’s equity portfolio: Myriad Genetics, Inc. (NASDAQ:MYGN), a $2.5 billion market cap company engaged in the discovery and commercialization of transformative tests which assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Over the first quarter, Mr. Blutt’s fund acquired 1.74 million shares, valued at approximately $58 million. However, this stake becomes quite small when compared to Royce & Associates’. The fund managed by Chuck Royce owns about $314 million in the company’s stock.

Furiex Pharmaceuticals Inc (NASDAQ:FURX) is the only one of Consonance’s top five positions for Q1 that saw a decrease in its stakes. However, the bet placed on this $1.1 billion market cap drug development collaborate company is still quite big: 616,495 shares, worth about $64 million. This position makes Consonace the largest hedge fund shareholder at the company. Second in rank, with about half the shares (376,365), is Israel Englander’s Millennium Management.

Back to bullish moves, we have Enanta Pharmaceuticals Inc (NASDAQ:ENTA), a $716 million market cap research and development focused biotechnology company. In its last 13F, Consonance disclosed ownership of 1.25 million shares (up 47% in relation to Q4), valued at roughly $48 million. Once again, Mr. Blutt’s fund is the company’s largest hedge fund stockholder

Finally, there’s BioScrip Inc (NASDAQ:BIOS), a $505 million market cap provider of home infusion and other home healthcare services. Over the quarter, the fund acquired 1.1 million shares, and now owns more than 5 million of them. This position, worth about $37 million, makes of the fund, yet again, the largest hedge fund investor, trailed, for a second time, by Englander’s Millennium Management, with 2.1 million shares.

Disclosure: Javier Hasse holds no position in any stocks mentioned.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Top 10 Most Expensive Luxury Cars in the World – 2014

Killer Small Business Ideas

The 50 Best Personal Finance Blogs

Most Expensive Apartments in New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!